nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abbreviations of chemotherapeutic combinations
|
|
|
2009 |
|
4 |
p. IV-VI nvt p. |
artikel |
2 |
Abbreviations of chemotherapeutic combinations
|
|
|
2007 |
|
4 |
p. IV-VI nvt p. |
artikel |
3 |
Abbreviations of Chemotherapeutic Combinations
|
|
|
2006 |
|
4 |
p. IV-VI nvt p. |
artikel |
4 |
Abbreviations of drugs
|
|
|
2009 |
|
4 |
p. I-III nvt p. |
artikel |
5 |
Abbreviations of Drugs
|
|
|
2007 |
|
4 |
p. I-III nvt p. |
artikel |
6 |
Abbreviations of Drugs
|
|
|
2006 |
|
4 |
p. I-III nvt p. |
artikel |
7 |
Angiogenesis inhibitors in clinical oncology
|
George, Daniel J. |
|
2006 |
|
4 |
p. 429-434 6 p. |
artikel |
8 |
Anti-angiogenesis approach to genitourinary cancer treatment
|
Aragon-Ching, Jeanny B. |
|
2009 |
|
4 |
p. 182-188 7 p. |
artikel |
9 |
Author Index
|
|
|
2007 |
|
4 |
p. 203- 1 p. |
artikel |
10 |
Author Index
|
|
|
2006 |
|
4 |
p. 573-574 2 p. |
artikel |
11 |
Biological Abbreviations
|
|
|
2009 |
|
4 |
p. VII-X nvt p. |
artikel |
12 |
Biological Abbreviations
|
|
|
2007 |
|
4 |
p. VII-X nvt p. |
artikel |
13 |
Biological Abbreviations
|
|
|
2006 |
|
4 |
p. VII-X nvt p. |
artikel |
14 |
Biology and treatment of malignant solid tumors in childhood
|
van den Berg, Henk |
|
2007 |
|
4 |
p. 177-191 15 p. |
artikel |
15 |
Central nervous system tumors
|
Ashby, Lynn S. |
|
2006 |
|
4 |
p. 475-513 39 p. |
artikel |
16 |
Contents
|
|
|
2007 |
|
4 |
p. 201-202 2 p. |
artikel |
17 |
Contents of Volume 1
|
|
|
2006 |
|
4 |
p. 569-572 4 p. |
artikel |
18 |
Copyright
|
|
|
2009 |
|
4 |
p. ii- 1 p. |
artikel |
19 |
Copyright
|
|
|
2007 |
|
4 |
p. ii- 1 p. |
artikel |
20 |
Copyright text
|
|
|
2006 |
|
4 |
p. ii- 1 p. |
artikel |
21 |
COX-2 inhibitors and colorectal cancer: The end or just a new beginning
|
Meyerhardt, Jeffrey A. |
|
2009 |
|
4 |
p. 154-156 3 p. |
artikel |
22 |
Cross resistance of melanoma to trail-induced apoptosis and chemotherapy
|
Zhang, Xu Dong |
|
2006 |
|
4 |
p. 435-441 7 p. |
artikel |
23 |
Development of abiraterone acetate, a 17-alpha hydroxylase C17,20-lyase inhibitor as a secondary hormonal therapy in prostate cancer
|
Aggarwal, Rahul |
|
2007 |
|
4 |
p. 171-175 5 p. |
artikel |
24 |
Development of novel agents for bladder cancer
|
Hahn, Noah M. |
|
2009 |
|
4 |
p. 160-169 10 p. |
artikel |
25 |
Editorial Board
|
|
|
2009 |
|
4 |
p. i- 1 p. |
artikel |
26 |
Editorial Board
|
|
|
2007 |
|
4 |
p. i- 1 p. |
artikel |
27 |
Editorial Board
|
|
|
2006 |
|
4 |
p. i- 1 p. |
artikel |
28 |
Genitourinary malignancies
|
Wilson, Shandra S. |
|
2006 |
|
4 |
p. 443-466 24 p. |
artikel |
29 |
Immunomodulatory agents in oncology
|
Zimmerman, Todd |
|
2009 |
|
4 |
p. 170-181 12 p. |
artikel |
30 |
Keyword Index
|
|
|
2007 |
|
4 |
p. 205-206 2 p. |
artikel |
31 |
Keyword Index
|
|
|
2006 |
|
4 |
p. 575-576 2 p. |
artikel |
32 |
Lymphomas
|
Santoro, Armando |
|
2006 |
|
4 |
p. 467-473 7 p. |
artikel |
33 |
Modulators of DNA methylation and histone acetylation
|
Donepudi, Sreekanth |
|
2007 |
|
4 |
p. 157-169 13 p. |
artikel |
34 |
News Round-Up
|
|
|
2009 |
|
4 |
p. 147-153 7 p. |
artikel |
35 |
Novel therapeutics in breast cancer—Looking to the future
|
Vora, Tushar |
|
2009 |
|
4 |
p. 189-205 17 p. |
artikel |
36 |
NSC-numbers
|
|
|
2009 |
|
4 |
p. XI- 1 p. |
artikel |
37 |
NSC-numbers
|
|
|
2007 |
|
4 |
p. XI- 1 p. |
artikel |
38 |
NSC-Numbers
|
|
|
2006 |
|
4 |
p. XI- 1 p. |
artikel |
39 |
Plasma cell dyscrasias and leukemias
|
Wiernik, Peter H. |
|
2006 |
|
4 |
p. 539-567 29 p. |
artikel |
40 |
Systemic therapy for gynecological neoplasms: Ovary, cervix and endometrium
|
Pecorelli, Sergio |
|
2006 |
|
4 |
p. 515-538 24 p. |
artikel |
41 |
Thymidylate synthase inhibitors
|
Ackland, Stephen P. |
|
2006 |
|
4 |
p. 403-427 25 p. |
artikel |
42 |
TROG 96.01: TTBF and PSAdt as surrogates for disease specific mortality
|
Hoimes, Christopher J. |
|
2009 |
|
4 |
p. 157-159 3 p. |
artikel |
43 |
Updates in adjuvant systemic treatment of breast cancer
|
McArthur, Heather L. |
|
2007 |
|
4 |
p. 193-199 7 p. |
artikel |